Medicare’s 2027 reset could raise drug costs and tighten eligibility

Changes due in 2027 will narrow some eligibility rules, raise Part D cost limits and expand virtual and chronic-care services, making open-enrolment choices more consequential.

Medicare beneficiaries should prepare for a set of changes taking effect in 2027 that could affect who qualifies for coverage, what prescription drugs cost, and how some chronic care services are delivered. With open enrolment approaching, the changes are worth reviewing now, especially because the choices people make for next year’s coverage will shape their costs and access to care in 2027.

One of the clearest shifts concerns eligibility. From 2027, Medicare coverage will be limited to US citizens and nationals, lawful permanent residents, Cuban-Haitian entrants and people lawfully living in the country as Compact of Free Association migrants. That is a tighter definition than the current rule, which allows coverage for US citizens and certain lawful noncitizens who have lived in the country for at least five years. The change makes legal status, not just length of residence, more central to eligibility.

Prescription drug coverage will also become slightly more expensive. The maximum Part D deductible is set to rise to $700 in 2027, up from $615 in 2026, while the annual out-of-pocket cap will increase to $2,400 from $2,100. Those limits apply to the most a plan may charge, not what every enrollee will pay, since some plans have lower deductibles or none at all. The Centres for Medicare & Medicaid Services has separately said Medicare Advantage premiums are projected to fall by 16.5% to an average $12 a month in 2027, while stand-alone Part D premiums are expected to edge up by less than $1 a month. Kaiser Family Foundation says the number of stand-alone drug plans available to the average beneficiary is likely to fall again, which could leave some people paying more if they stay put rather than shop around.

Beyond costs, CMS is expanding options for chronic disease management. The agency has launched the ACCESS model, short for Advancing Chronic Care with Effective, Scalable Solutions, as a voluntary programme for people enrolled in original Medicare. The model is designed to connect physicians with participating providers and support services that can help patients manage long-term conditions more effectively. CMS has also said the Medicare Diabetes Prevention Programme will be available virtually from 2027, giving eligible enrolees the choice of live online sessions or recorded lessons rather than attending in person.

The broader picture, according to CMS, is a programme that is trying to balance affordability, access and financial stability. The agency says its final 2027 payment policies will lift Medicare Advantage payments by an average 2.48%, while keeping the market stable and preserving choice for beneficiaries. For people approaching open enrolment, the practical lesson is straightforward: compare plans carefully, pay attention to deductibles and drug coverage, and check whether new care models or virtual prevention services could work better for your health needs.